Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis

Erica Ramstad; Ole Jakob Storebø; Trine Gerner; Helle B. Krogh; Mathilde Holmskov; Frederik L. Magnusson; Carlos R. Moreira-Maia; Maria Skoog; Camilla Groth; Donna Gillies; Morris Zwi; Richard Kirubakaran; Christian Gluud; Erik Simonsen

doi:10.21307/sjcapp-2018-003

Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis

Erica Ramstad^*, Ole Jakob Storebø, Trine Gerner, Helle B. Krogh, Mathilde Holmskov, Frederik L. Magnusson, Carlos R. Moreira-Maia, Maria Skoog, Camilla Groth, Donna Gillies, Morris Zwi, Richard Kirubakaran, Christian Gluud, Erik Simonsen

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Abstract

Background:There is little evidence in the literature on the association between methylphenidate treatment and psychotic symptoms in children and adolescents with attention-deficit/hyperactivity disorder (ADHD).Objective:We examine the occurrence of psychotic symptoms during methylphenidate treatment of children and adolescents with ADHD. The data arise from our two Cochrane systematic reviews on methylphenidate,

Originalsprog	Dansk
Sider (fra-til)	52-71
Antal sider	20
Tidsskrift	Scandinavian Journal of Child and Adolescent Psychiatry and Psychology
Vol/bind	6
Udgave nummer	1
DOI	https://doi.org/10.21307/sjcapp-2018-003
Status	Udgivet - 2018

Emneord

Publiceret originalartikel
attention-deficit/hyperactivity disorder
deficit hyperactivity disorder
Review
methylphenidate
open-label
adverse events
design characteristics
mood dysregulation
oros methylphenidate
psychotic symptoms
release methylphenidate
transdermal system
visual hallucinations

Adgang til dokumentet

10.21307/sjcapp-2018-003

http://www.exeley.com/exeley/journals/sj_child_adolescent_psychiatry_psychology/5/i_current/pdf/10.21307_sjcapp-2018-003.pdf

Citationsformater

Ramstad, E., Storebø, O. J., Gerner, T., Krogh, H. B., Holmskov, M., Magnusson, F. L., Moreira-Maia, C. R., Skoog, M., Groth, C., Gillies, D., Zwi, M., Kirubakaran, R., Gluud, C., & Simonsen, E. (2018). Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, 6(1), 52-71. https://doi.org/10.21307/sjcapp-2018-003

Ramstad, Erica ; Storebø, Ole Jakob ; Gerner, Trine et al. / Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis. I: Scandinavian Journal of Child and Adolescent Psychiatry and Psychology. 2018 ; Bind 6, Nr. 1. s. 52-71.

@article{a6bab6e08359454a84d6f7bb8c21db23,

title = "Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis",

abstract = "Background:There is little evidence in the literature on the association between methylphenidate treatment and psychotic symptoms in children and adolescents with attention-deficit/hyperactivity disorder (ADHD).Objective:We examine the occurrence of psychotic symptoms during methylphenidate treatment of children and adolescents with ADHD. The data arise from our two Cochrane systematic reviews on methylphenidate,",

keywords = "Publiceret originalartikel, attention-deficit/hyperactivity disorder, deficit hyperactivity disorder, Review, methylphenidate, open-label, adverse events, design characteristics, mood dysregulation, oros methylphenidate, psychotic symptoms, release methylphenidate, transdermal system, visual hallucinations",

author = "Erica Ramstad and Storeb{\o}, {Ole Jakob} and Trine Gerner and Krogh, {Helle B.} and Mathilde Holmskov and Magnusson, {Frederik L.} and Moreira-Maia, {Carlos R.} and Maria Skoog and Camilla Groth and Donna Gillies and Morris Zwi and Richard Kirubakaran and Christian Gluud and Erik Simonsen",

year = "2018",

doi = "10.21307/sjcapp-2018-003",

language = "Dansk",

volume = "6",

pages = "52--71",

journal = "Scandinavian Journal of Child and Adolescent Psychiatry and Psychology",

issn = "2245-8875",

publisher = "Psychiatric Research Unit, Region Zealand",

number = "1",

}

Ramstad, E, Storebø, OJ, Gerner, T, Krogh, HB, Holmskov, M, Magnusson, FL, Moreira-Maia, CR, Skoog, M, Groth, C, Gillies, D, Zwi, M, Kirubakaran, R, Gluud, C & Simonsen, E 2018, 'Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis', Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, bind 6, nr. 1, s. 52-71. https://doi.org/10.21307/sjcapp-2018-003

Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis. / Ramstad, Erica; Storebø, Ole Jakob; Gerner, Trine et al.
I: Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, Bind 6, Nr. 1, 2018, s. 52-71.

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

TY - JOUR

T1 - Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis

AU - Ramstad, Erica

AU - Storebø, Ole Jakob

AU - Gerner, Trine

AU - Krogh, Helle B.

AU - Holmskov, Mathilde

AU - Magnusson, Frederik L.

AU - Moreira-Maia, Carlos R.

AU - Skoog, Maria

AU - Groth, Camilla

AU - Gillies, Donna

AU - Zwi, Morris

AU - Kirubakaran, Richard

AU - Gluud, Christian

AU - Simonsen, Erik

PY - 2018

Y1 - 2018

N2 - Background:There is little evidence in the literature on the association between methylphenidate treatment and psychotic symptoms in children and adolescents with attention-deficit/hyperactivity disorder (ADHD).Objective:We examine the occurrence of psychotic symptoms during methylphenidate treatment of children and adolescents with ADHD. The data arise from our two Cochrane systematic reviews on methylphenidate,

AB - Background:There is little evidence in the literature on the association between methylphenidate treatment and psychotic symptoms in children and adolescents with attention-deficit/hyperactivity disorder (ADHD).Objective:We examine the occurrence of psychotic symptoms during methylphenidate treatment of children and adolescents with ADHD. The data arise from our two Cochrane systematic reviews on methylphenidate,

KW - Publiceret originalartikel

KW - attention-deficit/hyperactivity disorder

KW - deficit hyperactivity disorder

KW - Review

KW - methylphenidate

KW - open-label

KW - adverse events

KW - design characteristics

KW - mood dysregulation

KW - oros methylphenidate

KW - psychotic symptoms

KW - release methylphenidate

KW - transdermal system

KW - visual hallucinations

U2 - 10.21307/sjcapp-2018-003

DO - 10.21307/sjcapp-2018-003

M3 - Artikel

SN - 2245-8875

VL - 6

SP - 52

EP - 71

JO - Scandinavian Journal of Child and Adolescent Psychiatry and Psychology

JF - Scandinavian Journal of Child and Adolescent Psychiatry and Psychology

IS - 1

ER -

Ramstad E, Storebø OJ, Gerner T, Krogh HB, Holmskov M, Magnusson FL et al. Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology. 2018;6(1):52-71. doi: 10.21307/sjcapp-2018-003